Combining triglyceride glucose-body mass index and high-sensitivity C-reactive protein to predict cardiovascular disease: results from a national cohort and a clinical verified cohort

These results emphasize the importance of simultaneously considering both TyG-BMI index and hsCRP levels in risk stratification for CVD, highlighting their combined potential to enhance early identification of high-risk individuals. Importantly, TyG-BMI also demonstrated significant predictive value for adverse outcomes in patients after PCI.